PharmaRadar360

PharmaRadar360

🇺🇸·2d agoIndustry

United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion Authorization

Publisher

U
United Therapeutics (IR)

USA

This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
United Therapeutics (IR)
Region
USA
Scope
Industry
Published
September 8, 2026

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on ir.unither.com

Leave the platform to read the original full article on the publisher site.

Source: United Therapeutics (IR)

Scope: Industry

Open original article
United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion Authorization | PharmaRadar360